Lyka Labs Ltd.
| BSE: 500259 | Sector: Health care |
| NSE: LYKALABS | ISIN Code: INE933A01014 |
| BSE 00:00 | 18 Sep | 19.20 |
-0.10 (-0.52%) |
OPEN
19.50 |
HIGH
19.80 |
LOW
19.00 |
| NSE 00:00 | 18 Sep | 19.10 |
-0.20 (-1.04%) |
OPEN
19.75 |
HIGH
19.80 |
LOW
18.95 |
| OPEN | 19.50 |
| PREVIOUS CLOSE | 19.30 |
| VOLUME | 2211 |
| 52-Week high | 24.85 |
| 52-Week low | 9.70 |
| P/E | |
| Mkt Cap.(Rs cr) | 55 |
| Buy Price | 19.00 |
| Buy Qty | 997.00 |
| Sell Price | 20.25 |
| Sell Qty | 1029.00 |
Lyka Labs Ltd. (LYKALABS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 523.25 | 2.23 | 564.90 | 315.20 | 125543.37 |
| Divi's Lab. | 3347.20 | 4.24 | 3388.00 | 1571.25 | 88851.42 |
| Dr Reddy's Labs | 5326.70 | 10.36 | 5497.00 | 2497.60 | 88561.71 |
| Cipla | 806.85 | 7.29 | 819.00 | 356.75 | 65060.35 |
| Biocon | 453.80 | 2.65 | 463.55 | 212.40 | 54456.00 |
| Lupin | 1085.50 | 4.58 | 1121.85 | 505.00 | 49189.43 |
| Torrent Pharma. | 2873.60 | 1.24 | 3040.00 | 1554.65 | 48627.06 |
| Aurobindo Pharma | 828.40 | 2.14 | 967.60 | 281.15 | 48535.96 |
| Cadila Health. | 409.15 | 3.79 | 422.80 | 212.70 | 41884.69 |
| Abbott India | 16512.90 | 0.43 | 18569.00 | 9722.00 | 35089.91 |
| Alkem Lab | 2856.80 | 0.63 | 3089.55 | 1850.00 | 34153.04 |
| Piramal Enterp. | 1350.20 | -1.90 | 1860.08 | 608.00 | 30453.76 |
| Glaxosmi. Pharma | 1698.95 | -3.61 | 1805.00 | 1046.40 | 28781.91 |
| Ipca Labs. | 2172.85 | 1.16 | 2235.80 | 844.20 | 27453.96 |
| Apollo Hospitals | 1828.75 | 2.89 | 1871.00 | 1047.45 | 25441.57 |
| Pfizer | 4986.05 | 0.61 | 5230.00 | 3069.40 | 22811.18 |
| Syngene Intl. | 567.75 | 1.48 | 594.75 | 201.65 | 22710.00 |
| Sanofi India | 8478.30 | -2.67 | 8999.00 | 5610.00 | 19525.53 |
| Alembic Pharma | 961.70 | -1.29 | 1128.00 | 436.10 | 18902.21 |
| Dr Lal Pathlabs | 1989.50 | 0.66 | 2029.85 | 1181.80 | 16580.49 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
